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Introduction. The appropriate use of antibiotics is a global pri-
ority in order to avoid antibiotic resistance. Up to 50% of antibi-
otics usage in hospital is inappropriate (e.g. prolonged surgical 
prophylaxis, “defensive medicine” approach). In 2015, at the Fer-
rara University Hospital, an antimicrobial stewardship interven-
tion to reduce antimicrobial prescription at the time of hospital 
discharge in patients at risk of surgical site infection was imple-
mented. This programme included: update meetings for health 
professionals, focused meetings for critical wards, reviews of 
some surgical prophylaxis protocols, recommendations to reduce 
broad-spectrum antimicrobials use, and planning of an audit. The 
purpose of this study has been to evaluate the effect of this antimi-
crobial stewardship programme.
Methods.  To evaluate the effect of this intervention, a study has 
been carried out including inpatients in surveillance for surgical 
site infection who had surgery during the last quarter of 2014 
(pre-intervention group; 461 patients) and of 2015 (post-interven-
tion group; 532 patients).
Results. The proportion of patients with prescription of at least 
one antimicrobial at discharge decreased from 33% to 24.4% 
(p  =  0.002). The most prescribed categories of antimicrobials 
in both groups were the combination of penicillins with beta-
lactamase inhibitors (with prescription rate reduced from 21.9% 
to 18%; p  =  0.13) and fluoroquinolones (from 8.2% to 3.2%; 
p < 0.001). 
Conclusions. This statistically significant reduction in antimi-
crobial prescription after the intervention was registered with-
out a change in surgical site infections rate (from 3.5% to 3.2%; 
p = 0.08). Therefore, this intervention was effective in reducing 
the antimicrobial prescription at discharge, without affecting 
patients’ safety.
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Summary
Introduction
The rapid worldwide antibiotic-resistant bacteria spread 
is affecting the efficacy of antibiotics [1, 2]. Antibiotic 
resistance mainly results from the excessive and inap-
propriate use of antibiotics [1, 3]. The consumption of 
antibiotics is globally increasing every year, creating the 
preconditions of a global public health emergency [4].
Antibiotic resistance causes an increase in morbidity and 
mortality as well as an increase in hospitalizations and 
costs [5, 6]. In Europe, infections sustained by antimi-
crobial resistant germs cause about 25,000 deaths every 
year and a cost of at least 1.5 billion euros [6, 7].
Appropriate use of antibiotics can help to counteract 
bacteria-resistance development and to preserve drug’s 
efficacy for the use in the future [8]. Since a long time, 
the international scientific community has underlined 
the need to hinder this phenomenon and to sustain the 
proper use of antibiotics, that is their targeted, rational 
and moderate use [9]. Despite these international guide-
lines, it is estimated that about 20-50% of antibiotics 
usage in acute-care hospitals is either unnecessary or 
inappropriate [10]. This phenomenon unnecessarily ex-
poses patients to potential side effects of antimicrobial 
therapy [11].
Italy is among the European countries with the highest 
levels of antibiotic resistance and with the highest use 
of antibiotics both in the community and in the hospital 
setting [6, 7, 12].
In the hospital setting, about 40-50% of all antibiotic 
prescriptions involves peri-operative antibiotic prophy-
laxis [13], which is one of the tools to reduce the inci-
dence of surgical site infections (SSI) [14].
According to guidelines in use and to scientific evidence, 
surgical prophylaxis should be limited to perioperative 
period, be given immediately prior to the onset of sur-
gery and not extended beyond 24 hours from the surgical 
procedure [13, 15]. However, in many cases antibiotic 
prophylaxis is prolonged in the post-operative period, in 
the attempt to reduce the incidence of SSI [14, 15]. This 
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misuse of antibiotics is not justified, as it is ineffective 
in further reducing the incidence of SSI, can cause an 
increase in antibiotic resistance, and can predispose to 
serious infections [13-15].
This phenomenon may be accompanied by an inappro-
priate or excessive prescription for antibiotics at hospi-
tal discharge, related to a “defensive medicine” behav-
ior [16].
Several studies demonstrate that hospital-based pro-
grams dedicated to enhance antimicrobials’ use, gener-
ally known as antimicrobial stewardship programs, can 
both reduce hospital acquired infections and multi-drug 
resistant microorganisms, limiting in addition adverse 
events resulting from antimicrobials use [17]. 
Several methods of antimicrobial stewardship can be im-
plemented in order to counteract this attitude (e.g. audit 
and feedback, continuing education, recommendations, 
etc.) [18], even if there is no unanimous consensus on 
the impact of different interventions [19].
The purpose of this study has been to evaluate the effect 
of an antimicrobial stewardship intervention focused on 
the reduction of antimicrobial prescription at the time 
of hospital discharge in patients at risk of SSI involved 
in a surveillance programme at the Ferrara University 
Hospital. 
Methods
Setting 
Ferrara University Hospital is an Italian tertiary pub-
lic acute care hospital with 637 ordinary and 84 day-
hospital beds, 24,023 regular admissions (excluding 
healthy new-borns), 8,022 admissions in day-hospital 
and 10,055 surgical operations per year (data referring 
to 2016). 
Antimicrobial stewardship intervention
With reference to existing data, demonstrating the op-
portunity to optimize antimicrobial prescription at dis-
charge, particularly in surgical patients, in 2015 Ferrara 
University Hospital implemented a multidisciplinary an-
timicrobial stewardship intervention including five main 
components: three update meetings for health profes-
sionals, focused meetings for critical wards, reviews of 
some surgical prophylaxis protocols, recommendations 
to reduce broad-spectrum antimicrobials use, and plan-
ning of an audit.
The three update meetings focused on the most 
emerging infections in our hospital (infections due to 
Clostridium difficile, pneumonia, sepsis) and on re-
sponsible antimicrobial use. These meetings involved 
medical and nursing personnel and were held by a 
team, called “Operative Group for the responsible use 
of antimicrobials”, composed of an infectious disease 
specialist, a microbiologist, a specialist in hygiene and 
preventive medicine (responsible for hospital infection 
control), and a nurse specialized in infection control. 
During each meeting the epidemiological characteris-
tics, risk factors and hospital guidelines for diagnosis 
and therapy were discussed, with particular attention 
to the appropriate use of antimicrobials during the 
whole hospital stay, discharge included. In particu-
lar it was asked for the reduction of fluoroquinolones 
use, that were found to be overused in the past years if 
compared to regional data (e.g. 23.9 vs 14.4 DDD/100 
inpatient days in 2013) [20]. 
Furthermore, the team performed focused meetings with 
health workers of the surgical units that showed the high-
est prescription of antimicrobials on discharge in 2014, 
in order to find out specific solutions. 
Then, a review of some perioperative chemoprophylaxis 
protocols was made. 
Finally, was highlighted the indication to follow the in-
stitution’s guidelines to reduce the prescription for some 
types of antimicrobials (in particular broad-spectrum 
ones) and to indicate the motivation for the antimicrobial 
prescription in the discharge letter.
During these interventions, the surgical units staff was 
informed that in the future would have been performed 
an audit in order to check the situation about antimicro-
bial prescription at discharge.
Inclusion and exclusion criteria 
In order to determine the impact of the antimicrobial 
stewardship intervention, a study including surgical in-
patients involved in the Italian national surgical site in-
fection surveillance programme (SNICh) [21] had been 
performed.
We chose this group of subjects as these patients have a 
short hospital stay and a higher risk of developing SSIs, 
being therefore potentially exposed to a prolonged an-
timicrobial prophylaxis or to an inappropriate prescrip-
tion at discharge. The study involved all inpatients un-
dergoing an operative procedure included in the SNICh 
surveillance program during the last quarter of 2014 
(pre-intervention group) and the last quarter of 2015 
(post-intervention group). 
In this study, surgical inpatients in SNICh surveillance 
admitted in surgical units that did not use the digital dis-
charge letter (otolaryngology, gynaecology, obstetrics, 
and ophthalmology wards) or patients died during the 
hospital stay were excluded.
Data collection 
The same method to collect data for both periods was 
used. Demographic, clinical and surgical characteristics 
of patients were extracted from computerized register 
of surgical operations. Information on the antimicrobi-
als prescribed at discharge and the characteristics of the 
post-operative course were extracted from the digital 
discharge letters stored in institution’s data warehouse.
Data were recorded in anonymous form on an electronic 
worksheet for processing. For each patient the informa-
tion considered were the following: age, gender, and 
duration of hospital stay (days); American Society of 
Anesthesiologists (ASA) score [22]; type of surgery 
(elective or urgent-emergency surgery); operative pro-
cedures, surgical wound contamination class and pros-
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thetic implant material classified or definite according 
to the SNICh protocol [21]; duration of operative pro-
cedure (minutes); characteristics of the post-operative 
clinical course described in the digital discharge letter 
(regular or complicated); characteristics of antimicrobi-
als prescribed at hospital discharge (number and typol-
ogy of active principle, classified according to the Ana-
tomical Therapeutic Chemical classification - ATC [23]) 
and characteristics of SSI (according to the SNICh pro-
tocol [21]), when applicable.
Data collection related to the two groups was completed 
in December 2015 and 2016, respectively. 
Objectives
The primary purpose of this study was to assess if a sta-
tistically significant change in antimicrobial prescription 
behaviour at discharge occurred after the stewardship in-
tervention. Secondarily, it was checked if a change in 
SSIs rate among the studied groups occurred.
Statistical analysis
Pearson’s chi-square test, Fisher’s exact test, and t-test 
were used to perform comparisons between the periods, 
as appropriate. P value < 0.05 was considered statisti-
cally significant. All analyses were performed using 
MedCalc Version 17.6.
Results
The study included 993 surgical patients: 461 before 
the intervention of antimicrobial stewardship (pre-inter-
vention group) and 532 after the intervention (post-in-
tervention group). There was no statistically significant 
difference between the two groups in baseline demo-
graphic characteristics (Tab. I). Concerning the surgical 
characteristics of patients (Tab. II), in the post-interven-
tion group there was a statistically significant increase 
in patients undergoing breast surgery, probably due to 
the reorganization of general surgery ward, which took 
place in 2015, and led to the creation of a breast surgery 
dedicated ward.
Overall, the proportion of surgical patients with pre-
scription of antimicrobials at discharge decreased signif-
icantly, from 33% in the pre-intervention group to 24.4% 
in the post-intervention group (p = 0.002).
A statistically significant decrease in the prescription of 
antimicrobials occurred in (Tab. I and Tab. II): female gen-
der (42% pre-intervention vs 27.8% post-intervention; 
p < 0.001); patients with ASA score II (38.5% vs 22.2%; 
p < 0.001); urgent-emergency surgery (48.4% vs 24%; 
p < 0.001); breast surgery (94.1% vs 47.5%; p < 0.001), 
gallbladder surgery (44.2% vs 10.8%; p < 0.001), and 
kidney surgery (63.6% vs 18.2%; p = 0.03); clean-con-
taminated class of surgical wound (33.3% vs 19.5%; 
p = 0.02); patients operated without prosthetic material 
implant (30.5% vs 20.6%; p = 0.002); surgery patients 
with post-operative course described as regular (33.6% 
vs 24.4%; p = 0.005).
Regarding the characteristics of antimicrobials (Tab. 
III), the most prescribed Anatomical Therapeutic Chem-
ical categories in both periods were the combinations of 
penicillins with beta-lactamase inhibitors, in large part 
amoxicillin and enzyme inhibitors, prescribed in 21.9% 
of subjects belonging to the pre-intervention group and 
in 18% of patients in the post-intervention group. Al-
Tab. I. Demographic and clinical characteristics of patients.
Variable
Pre-intervention Group Post-intervention Group
P value  
(Pts AM)No. Pts
(n = 461)
No. Pts AM
(n = 152)
Pts AM%
No. Pts 
(n = 532)
No. Pts AM 
(n = 130)
Pts AM%
Age, mean 
(SD)
60.1
(20.8)
58.9
(19.3)
-
60.0
(19.6)
59.4
(19.0)
- 0.83
Female 226 95 42.0 284 79 27.8 < 0.001
Male 235 57 24.3 248 51 20.6 0.33
Hospital length of stay, mean 
days (SD)
8.9
(11.2)
7.8
(9.5)
-
7.8
(9.5)
6.4
(6.5)
-
0.15
ASA score:
I
II
III
IV
29
187
184
48
9
72
54
14
31.0
38.5
29.3
29.2
44
212
221
35
12
47
60
5
27.3
22.2
27.1
14.3
0.73
< 0.001
0.62
0.11
Missing record 13 3 23.1 20 6 30.0 1.0
Post-operative clinical course:
Regular
Complicated
363
98
122
30
33.6
30.6
401
131
98
32
24.4
24.4
0.005
0.30
Pts who developed a SSI 16 9 56.3 17 4 23.5 0.08
Pts = patients; Pts AM = patients with at least one antimicrobial prescription at discharge; SD = standard deviation; ASA = American Society of Anesthe-
siologists; SSI = Surgical Site Infection.
P. ANTONIOLI ET AL.
E142
though, this reduction was not statistically significant 
(p = 0.13). Differently, a statistically significant differ-
ence was recorded in the prescription of fluoroquinolo-
nes (decreasing from 8.2% to 3.2% comparing pre- and 
post-intervention group, respectively; p < 0.001) and in 
the prescription of third-generation cephalosporin (in-
creasing from 0.4% to 2.1%; p = 0.03). 
The indication for antimicrobial prescription on dis-
charge (e.g. ongoing therapy in discharge) was recorded 
in the digital discharge letters for 9.9% pre-intervention 
and 24.6% of patients post-intervention (p < 0.001). Fi-
nally (Tab. I), the proportion of patients who developed 
an SSI during the SNICh surveillance period (within 30 
days after the operative procedure, for patients operated 
Tab. II. Surgical characteristics of patients.
Variable
Pre-intervention Group Post-intervention Group
P value 
(Pts AM)No. Pts
(n = 461)
No. Pts AM
(n = 152)
Pts AM%
No. Pts 
(n = 532)
No. Pts AM 
(n = 130)
Pts AM%
Surgical procedures:
Elective surgery
Urgent or emergency surgery
370
91
108
44
29.2
48.4
403
129
99
31
24.6
24.0
0.15
< 0.001
Operative procedure:
Breast surgery
Herniorrhaphy
Gallbladder surgery
Colon surgery
Laminectomy
Hip prosthesis
Thoracic surgery
Craniotomy
Kidney surgery
Spinal fusion
Other
51
62
52
52
54
31
23
22
22
14
78
48
9
23
11
0
5
5
0
14
1
36
94.1
14.5
44.2
21.2
0
16.1
21.7
0
63.6
7.1
46.2
101
75
74
73
41
22
25
21
11
14
75
48
13
8
8
2
3
10
3
2
3
30
47.5
17.3
10.8
11.0
4.9
13.6
40.0
14.3
18.2
21.4
40.0
< 0.001
0.66
< 0.001
0.12
0.18
1.0
0.18
0.11
0.03
0.60
0.44
Prosthetic material implant:
Yes
No
120
341
48
104
40.0
30.5
133
399
48
82
36.1
20.6
0.52
0.002
Duration of operative 
procedure, mean minutes (SD)
244
(193)
249
(206)
-
235
(141)
255
(179)
- 0.79
Surgical Wound Classification:
Clean
Clean-Contaminated
Contaminated
Dirty-Infected
Missing record
243
87
18
16
97
81
29
6
7
29
33.3
33.3
33.3
43.8
29.9
306
118
24
19
65
82
23
8
4
13
26.8
19.5
33.3
21.1
20.0
0.10
0.02
1.0
0.27
0.16
Pts = patients; Pts AM = patients with at least one antimicrobial prescription at discharge; SD = standard deviation.
Tab. III. Characteristics of antimicrobials prescribed at hospital discharge (absolute value and percentage of patients with prescription of an-
timicrobial).
ATC category
Pre-intervention Group
No. Pts (%) 
(n = 461)
Post-intervention 
Group No. Pts (%) 
(n = 532)
P value
Combinations of penicillins, incl. beta-lactamase inhibitors 101 (21.9) 96 (18.0) 0.13
Fluoroquinolones 38 (8.2) 17 (3.2) < 0.001
Imidazole derivatives 9 (2.0) 6 (1.1) 0.29
Third-generation cephalosporins 2 (0.4) 11 (2.1) 0.03
Macrolides 2 (0.4) 5 (0.9) 0.46
Other 10 (2.2) 9 (1.7) 0.58
ATC = Anatomical Therapeutic Chemical; Pts = patients.
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without prosthetic material implant, and within 1 year 
for procedures with prosthetic material implant) [21] did 
not significantly change comparing the two groups (3.5% 
pre-intervention vs 3.2% post-intervention; p = 0.08). 
Discussion
The need of our antimicrobial stewardship intervention 
originated from the analysis of antimicrobial prescrip-
tion data of the last quarter of 2014 (Tabs I, II and III), 
higher than the regional mean. It could be speculated 
that this over prescription originated from an unjusti-
fied attitude in prolonging the surgical prophylaxis over 
the limit suggested by national guidelines [13] or from 
a “defensive medicine” behavior for the aim of reducing 
the risk of SSI. 
For this reason, Ferrara University Hospital’s “Opera-
tive Group for the responsible use of antimicrobials” 
implemented a multidisciplinary intervention in order to 
reduce this excessive antimicrobial prescription at dis-
charge, without affecting patients’ safety. 
The comparison between pre- and post-intervention 
groups showed a statistically significant decrease 
(-8.6%; p = 0.002) in antimicrobial prescription at dis-
charge. However, we did not observe a change in SSIs 
rate among the studied groups (from 3.5% to 3.2%; 
p = 0.08).
The change in prescription was particularly significant in 
breast surgery (Tab. II), that was, indeed, one of the most 
critical wards in the first year of data collection, prob-
ably due to poor compliance to the local surgical che-
moprophylaxis guidelines. Other statistically significant 
reductions in antimicrobial prescription at discharge oc-
curred in urgent-emergency surgery, in patients without 
a prosthetic implant and in patients with postoperative 
course described as regular. Probably these reductions 
represent an attempt to limit unnecessary prescriptions, 
according to the recommendations about the appropriate 
use of antimicrobials. 
Concerning the type of used antimicrobial, there was a 
statistically significant reduction in prescription of fluo-
roquinolones, as suggested during the update meetings. 
Conversely, prescription of combinations of penicillins 
with beta-lactamase inhibitors, in large part amoxicillin 
and enzyme inhibitors, continued to be critical. Moreo-
ver, an inexplicable increase in the prescription of third-
generation cephalosporin was recorded, even if the abso-
lute value remained limited.
In both groups, the indication for antimicrobial prescrip-
tion on discharge was explicitly reported in the minority 
of digital discharge letters. However, the presence of ex-
plicit motivation significantly increased, comparing pre- 
and post-intervention groups, reflecting the indications 
given at the time of the intervention.
One of the main limitations of this study is represented 
by the short period of examination (last quarter of the 
years in study), because it could be not representative 
of the whole year and/or could not detect potential long-
term changes due to the intervention. Another important 
limitation is that the number of some categories of op-
erative procedures are not homogeneous in the two years 
in study (e.g. breast surgery).
Conclusions
This study seems to demonstrate that multidiscipli-
nary interventions of antimicrobial stewardship are ef-
fective in influencing excessive prescription of these 
drugs at discharge, without affecting patients’ safety. 
These results confirm, as other studies have demon-
strated  [17, 24, 25], that antimicrobial stewardship pro-
grams are effective in reducing and improving antibiotic 
prescription. Therefore, these programs are an important 
part of good practices to be maintained for an efficient 
infection risk management. 
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